M
Montserrat Fitó
Researcher at Carlos III Health Institute
Publications - 324
Citations - 12361
Montserrat Fitó is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 56, co-authored 269 publications receiving 9601 citations. Previous affiliations of Montserrat Fitó include Ramon Llull University.
Papers
More filters
Journal ArticleDOI
Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation--a randomized controlled trial.
Jaume Marrugat,María-Isabel Covas,Montserrat Fitó,Helmut Schröder,Elisabet Miró-Casas,Eva Gimeno,M. Carmen López-Sabater,Rafael de la Torre,Magí Farré +8 more
TL;DR: The hypothesis that virgin olive oil consumption could provide benefits in the prevention of oxidative processes is supported, as dose-dependent changes in oxidative stress markers, and phenolic compounds in urine, were observed with the phenolic content of the olive oil administered.
Journal ArticleDOI
Cardiovascular Risk Factors in Spain in the First Decade of the 21st Century, a Pooled Analysis With Individual Data From 11 Population-Based Studies: the DARIOS Study
María Grau,Roberto Elosua,Antonio Cabrera de León,María Jesús Guembe,José Miguel Baena-Díez,Tomás Vega Alonso,Francisco Javier Félix,Belén Zorrilla,Fernando Rigo,José Lapetra,Diana Gavrila,Antonio Segura,Héctor Sanz,Daniel Fernández-Bergés,Montserrat Fitó,Jaume Marrugat +15 more
TL;DR: Prevalence of high blood pressure, dyslipidemia, obesity, tobacco use and diabetes is high, and presence of the most prevalent cardiovascular risk factors in the Canary Islands, Extremadura and Andalusia was greater than the mean of the 11 studies.
Journal ArticleDOI
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
Rafael de la Torre,Susana Solá,Meritxell Pons,Arnaud Duchon,María Martínez de Lagrán,Magí Farré,Montserrat Fitó,Bessy Benejam,Klaus Langohr,Joan Rodríguez,Mitona Pujadas,Jean Charles Bizot,Aida Cuenca,Nathalie Janel,Silvina Catuara,María Isabel Covas,Henri Bléhaut,Yann Herault,Jean M. Delabar,Mara Dierssen +19 more
TL;DR: EGCG is a promising therapeutic tool for cognitive enhancement in DS, and its efficacy may depend of Dyrk1A inhibition, and plasma homocysteine levels are used as an efficacy biomarker in the human study.
Journal ArticleDOI
Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease
Marta Guasch-Ferré,Marta Guasch-Ferré,Nancy Babio,Nancy Babio,Miguel Ángel Martínez-González,Miguel Ángel Martínez-González,Dolores Corella,Dolores Corella,Emilio Ros,Sandra Martín-Peláez,Ramon Estruch,Ramon Estruch,Fernando Arós,Enrique Gómez-Gracia,Enrique Gómez-Gracia,Miquel Fiol,José Manuel Santos-Lozano,Lluis Serra-Majem,Lluis Serra-Majem,Mònica Bulló,Mònica Bulló,Estefanía Toledo,Estefanía Toledo,Rocío Barragán,Rocío Barragán,Montserrat Fitó,Alfredo Gea,Alfredo Gea,Jordi Salas-Salvadó,Jordi Salas-Salvadó +29 more
TL;DR: Intakes of MUFAs and PUFAs were associated with a lower risk of CVD and death, whereas SFA and trans-fat intakes were associated inversely associated with CVD.
Journal ArticleDOI
Plasma Branched-Chain Amino Acids and Incident Cardiovascular Disease in the PREDIMED Trial
Miguel Ruiz-Canela,Miguel Ruiz-Canela,Estefanía Toledo,Estefanía Toledo,Clary B. Clish,Adela Hruby,Liming Liang,Jordi Salas-Salvadó,Cristina Razquin,Cristina Razquin,Dolores Corella,Dolores Corella,Ramon Estruch,Emilio Ros,Emilio Ros,Montserrat Fitó,Enrique Gómez-Gracia,Enrique Gómez-Gracia,Fernando Arós,Miquel Fiol,José Lapetra,Lluis Serra-Majem,Lluis Serra-Majem,Miguel Ángel Martínez-González,Miguel Ángel Martínez-González,Frank B. Hu,Frank B. Hu +26 more
TL;DR: Higher concentrations of baseline BCAAs were associated with increased risk of CVD, especially stroke, in a high cardiovascular risk population in a case-cohort study within the Prevención con Dieta Mediterránea.